Impact of potential drug-drug interactions (PDDI) on adherence to endocrine therapy (ET) among patients with breast cancer (BC) in the Health Improvement Network (THIN)

May-22

Oncology Pharmacoepidemiology Women's Health

AUTHORS : Dr Elie Rassy, Breast Cancer Unit, Medical Oncology Department, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France – Email: elie.rassy@gustaveroussy.fr – Profile (Precision Cancer Medicine): https://pcm.amegroups.com/user/view/71939/157

JOURNAL : Annals of Oncology

REFERENCE: 33(S3):S228-S229

DOI : 10.1016/j.annonc.2022.03.246

Impact of potential drug-drug interactions (PDDI) on adherence to endocrine therapy (ET) among patients with breast cancer (BC) in the Health Improvement Network (THIN)

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease